Revelation Biosciences appoints Lakhmir Chawla to board; Curt LaBelle resigns

REVELATION BIOSCIENCES, INC.

Curt LaBelle M.D. resigned from Board on Sept 27, 2023, not due to any disagreements.
Lakhmir Chawla M.D. appointed as Class C director to fill vacancy, effective same date.
Dr. Chawla is CEO of Stavro Medical; former CMO at Silver Creek Pharma and La Jolla Pharmaceutical.
He will serve on Compensation and Nominations & Corporate Governance Committees.
No transactions requiring Item 404(a) disclosure between Dr. Chawla and the company.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lakhmir Chawla

Director

REVB · REVELATION BIOSCIENCES, INC.

Effective: 2023-09-27
Filed: October 2, 2023, 7:59 PM ET

On September 27, 2023, the Board of Directors elected Lakhmir Chawla M.D. (age 53) to the Board of Directors, as a Class C Director to fill the vacancy created by the resignation of Dr. La Belle.

Departed

Curt LaBelle

Director

REVB · REVELATION BIOSCIENCES, INC.

Effective: 2023-09-27
Successor: Lakhmir Chawla
Filed: October 2, 2023, 7:59 PM ET

On September 27, 2023, Curt LaBelle, M.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the "Company").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lakhmir Chawla was elected as Director at REVELATION BIOSCIENCES, INC..

Action: elected
Role: Director

Exact text from the filing

On September 27, 2023, the Board of Directors elected Lakhmir Chawla M.D. (age 53) to the Board of Directors, as a Class C Director to fill the vacancy created by the resignation of Dr. La Belle.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Curt LaBelle resigned as Director at REVELATION BIOSCIENCES, INC..

Action: resigned
Role: Director

Exact text from the filing

On September 27, 2023, Curt LaBelle, M.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the "Company").

View on SEC.gov

REVELATION BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-051141

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.